Table 4.
Intergroup comparison of clinical parameters and levels of sclerostin between the test and control groups at 3 month
| 3rd month | Mean±SD | T | P |
|---|---|---|---|
| GI | |||
| Control | 0.5333±0.35187 | 1.057 | 0.247 (NS) |
| Test | 0.3667±0.49881 | ||
| BI | |||
| Control | 2.5333±0.74322 | 7.898 | 0.000 (HS) |
| Test | 0.5333±0.63994 | ||
| PPD (in mm) | |||
| Control | 3.47±0.640 | 3.439 | 0.002 (HS) |
| Test | 2.60±0.737 | ||
| CAL (in mm) | |||
| Control | 3.67±0.724 | 2.649 | 0.012 (S) |
| Test | 2.80±1.014 | ||
| SOST (in pg/ml) | |||
| Control | 140.6±41.930 | 5.212 | 0.000 (HS) |
| Test | 82.80±9.314 |
P<0.05. HS: Highly significant; S: Significant; SD: Standard deviation; CAL: Clinical attachment level; GI: Gingival index; BI: Bleeding index; PPD: Probing pocket depth; SOST: Sclerostin